Combination Bacillus Calmette–Guérin and indoleamine 2,3‐dioxygenase 1 inhibitor therapy of murine orthotopic bladder cancer

Saved in:
Bibliographic Details
Published inBJU international Vol. 126; no. 5; pp. 554 - 556
Main Authors Lee, Sze Han, Mahendran, Ratha, Tham, Sin Mun, Thamboo, Thomas Paulraj, Kioh, Dorinda Yan Qin, Tang, Lloyd Wei Tat, Chiong, Edmund, Esuvaranathan, Kesavan, Chan, Eric Chun Yong
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.11.2020
Subjects
Acetamides - pharmacology
Acetamides - therapeutic use
Animals
Antineoplastic Agents - pharmacology
Antineoplastic Agents - therapeutic use
BCG Vaccine - pharmacology
BCG Vaccine - therapeutic use
Bladder cancer
Dioxygenase
Indoleamine-Pyrrole 2,3,-Dioxygenase - antagonists & inhibitors
Kynurenine - blood
Mice
Neoplasms, Experimental - chemistry
Neoplasms, Experimental - drug therapy
Quinolines - pharmacology
Quinolines - therapeutic use
Urinary Bladder - chemistry
Urinary Bladder - drug effects
Urinary Bladder Neoplasms - chemistry
Urinary Bladder Neoplasms - drug therapy
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1464-4096
1464-410X
DOI:10.1111/bju.15201